Skip to main content
. 2020 May 4;40(5):BSR20200830. doi: 10.1042/BSR20200830

Table 2. The potential regulatory targets and pathways for ARDS therapeutic strategies.

Regulatory targets Downstream mediator Anti-ARDS pathway
MiR-494 NAD(P)H: quinone oxidoreductase 1 (NQO1); In a rat model of sepsis-associated ARDS, the up-regulation of miR-494 decreased the expression of the antioxidant factor NQO1 and inactivated the Nrf2 signaling pathway, which were responsible for significantly higher levels of IL-1β, IL-6, and TNF-α, suggesting a pro-inflammatory effect of miR-494 on sepsis-associated ARDS [48].
miR-199a Sirtuin1(SIRT1) MicroRNA-199a (miR-199a) exerted a protective effect on sepsis-induced ARDS and was negatively correlated with SIRT1 expression. The down-regulation of miR-199a up-regulated SIRT1 expression, which suppressed excessive inflammatory responses and inhibited cellular apoptosis in subjects with sepsis-induced ARDS [50].
Jun N-terminal kinase (JNK) and p38 Mitogen-activated protein kinase (MAPK) signal MAPK signaling is suppressed by blocking the phosphorylation of JNK and p38, which decreases the levels of the pro-inflammatory cytokines IL-6 and TNF-α and increases the level of the anti-inflammatory cytokine IL-10 to subsequently alleviate the inflammation in subjects with sepsis-induced ARDS [54].
RNFT2 IL-3Rα RNFT2 decreases the expression of IL-3Rα by targeting it for proteasomal degradation after inducing its ubiquitination at Lys357, which inhibited pro-inflammatory cytokine and immune cell release in rats' lung inflammation models [55].
LincRNA-p21 Thy-1 (CD90) The overexpression of lincRNA-p21 inhibits Thy-1 expression by inhibiting the acetylation of H3 and H4 at the Thy-1 promoter and remarkably suppressing the expression of the Thy-1 mRNA, which promotes the proliferation of the human lung fibroblasts cell line HLF1 [49].